Compare GE Aerospace (GE) vs Moderna, Inc. (MRNA) Price & Performance

GE AerospaceTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

GE Aerospace vs Moderna, Inc. — how do they compare? GE Aerospace trades at $340.22 (market cap $375.97B), while Moderna, Inc. trades at $63.97 (market cap $27.09B). The key difference: GE Aerospace is far larger — about 13.9× Moderna, Inc.'s market cap, and GE Aerospace pays a 0.52% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

	GE	MRNA
Market Cap	$375.97B	$27.09B
Sector	Industrials	Health
52-Week High	$378.68	$81.80
52-Week Low	$259.00	$22.36
Enterprise Value	$385.26B	$23.19B
Dividend Yield	0.52%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE Aerospace

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $64.11, down 4.94% over 24 hours, with a bullish technical outlook but mixed fundamentals. The company reported a net loss of -$2.82B in 2025 despite beating EPS estimates in recent quarters. Recent news highlights progress in oncology trials and an EU RSV vaccine contract, fueling investor optimism about pipeline expansion beyond COVID-19 vaccines.

Outlook: Long-term growth depends on successful pipeline commercialization, but high cash burn and negative margins pose risks. Analyst consensus is cautious with a $49 price target, suggesting 23.6% downside. Investors should weigh clinical successes against persistent profitability challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GE Aerospace beats Q2 earnings and revenue estimates on strong aerospace demand.Alex Lavoie · 3 hours agoBullish GE Aerospace expects strong Q2 2026 with EPS $1.86 and 16.8% revenue growth, stock target raised to $400.Rayan Ahmad · 21 hours agoBullish Mar Vista's U.S. Quality strategy gains 12.71% in Q2 2026, lagging broader market indexes.Seeking Alpha · 2 days agoBullish View details →

MRNA

Arbutus sues Pfizer/BioNTech over LNP patents, gets $178M from Moderna, plans $230M share buybackGlobeNewsWire · 11 hours agoNeutral Moderna's Q2 report expected uneventful; key focus on COVID vaccine demand and Phase III melanoma data.Proactive Investors · 2 days agoNeutral View details →

About GE Aerospace

General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.